OPPORTUNITY RADAR SCREENER COMPARE ANY 2 STOCKS

EXCHANGE TRADED FUND

SURI

Simplify Propel Opportunities ETF

$17.06 ▼ 0.14%

−$0.02 TODAY

FUND FACTS

Manager Simplify

Assets $73.73M

Expense ratio 2.82%

Inception Feb 7, 2023

Asset class Equity

Holdings 25

Volume 403

Avg volume 4.65K

ABOUT THIS FUND

The Simplify Propel Opportunities ETF (SURI) aims to deliver substantial long-term capital growth. It achieves this by investing in companies across the biotechnology, pharmaceutical, healthcare technology, and life sciences industries. These particular firms are selected because they are believed to be overlooked by investors, suggesting significant potential for their value to increase. Propel, the fund's sub-advisor, applies its deep scientific and commercial knowledge in health sciences to identify and select the most promising investment opportunities within this sector.

PRICE

$17.06 ▼ DOWN 0.14% (−$0.02)

HOLDINGS

TOP 20 OF 25 · 86.60% OF THE FUND

RANK STOCK WEIGHT SHARES VALUE

01

PAGP Plains GP Holdings LP 44.56% 1.27M $33.35M

02

ACHV Achieve Life Sciences, Inc. 9.02% 932.11K $6.75M

03

DCTH Delcath Systems, Inc. 4.64% 225.56K $3.47M

04

MIST Milestone Pharmaceuticals Inc. 3.39% 3.35M $2.54M

05

CORT Corcept Therapeutics Incorporated 3.29% 20.57K $2.46M

06

COLL Collegium Pharmaceutical, Inc. 2.74% 93.52K $2.05M

07

PHAT Phathom Pharmaceuticals, Inc. 2.27% 249.27K $1.7M

08

ABEO Abeona Therapeutics Inc. 1.88% 276.33K $1.4M

09

AQST Aquestive Therapeutics, Inc. 1.72% 278.72K $1.29M

10

OBIO Orchestra BioMed Holdings, Inc. 1.66% 219.39K $1.24M

11

KYTX Kyverna Therapeutics, Inc. 1.51% 182.6K $1.13M

12

CABA Cabaletta Bio, Inc. 1.46% 556.24K $1.1M

13

CMPS COMPASS Pathways plc 1.41% 90.38K $1.06M

14

IVA Inventiva S.A. 1.41% 313.48K $1.05M

15

LONA LeonaBio, Inc. 1.16% 149.28K $870.3K

16

PROK ProKidney Corp. 1.01% 483.74K $759.47K

17

ARTV Artiva Biotherapeutics, Inc. 0.95% 101.36K $709.49K

18

CLDX Celldex Therapeutics, Inc. 0.88% 21.63K $658.17K

19

PALI Palisade Bio, Inc. 0.86% 434.33K $642.81K

20

OCUL Ocular Therapeutix, Inc. 0.78% 81.05K $586K

SECTOR HOLDINGS

TECHNOLOGY IS 53.87% OF THE FUND

Healthcare 53.87%

Energy 46.13%

BY REGION

UNITED STATES IS 88.04% OF THE FUND

United States 88.04%

— Other 5.75%

Canada 3.39%

United Kingdom 1.41%

France 1.41%